Cardiovascular Pharmacology

Cardiovascular pharmacotherapy is still a very active field. The goal of this study is to outline recent key breakthroughs in cardiovascular pharmacotherapy, with an emphasis on a recently approved medicine for heart failure treatment.

Heart failure is a prominent cause of morbidity and mortality globally, despite all breakthroughs in pharmacological and therapeutic treatment. To treat heart failure, many new therapeutic advance tactics have been investigated, including cell transplantation, gene delivery or therapy, and cytokines or other small chemicals.

  • Track 1-1 Cotransporter
  • Track 2-2 Endothelial Progenitor Cell
  • Track 3-3 Blood Pressure
  • Track 4-4 Actinobacteria
  • Track 5-5 Leporidae

Related Conference of Cardiology